Compare Anheuser-Busch Inbev SA (BUD) vs ClearPoint Neuro Inc (CLPT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Anheuser-Busch Inbev SA vs ClearPoint Neuro Inc — how do they compare? Anheuser-Busch Inbev SA trades at $79.57 (market cap $159.01B), while ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M). The key difference: Anheuser-Busch Inbev SA is far larger — about 350.1× ClearPoint Neuro Inc's market cap, and Anheuser-Busch Inbev SA pays a 1.67% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| BUD | CLPT | |
|---|---|---|
Market Cap | $159.01B | $454.21M |
Sector | Consumer Staples | Health |
52-Week High | $86.48 | $29.60 |
52-Week Low | $57.93 | $8.66 |
Enterprise Value | $223.42B | $488.79M |
Dividend Yield | 1.67% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Anheuser-Busch Inbev SA
Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. After the SABMiller acquisition, the company's portfolio now contains five of the top 10 beer brands by sales and 18 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and U.S.-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev and in 2016 acquired SABMiller.
Read more on BUD →About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →
